According to the lnCAR (https://lncar.renlab.org/) website30, miR-27b-3p, which was previously reported to be a tumor suppressor in DLBCL, was predicted as a candidate target of HCP5 (Figure 4A). The gene discussed is HCP5; the disease is diffuse large B-cell lymphoma.